Pharmacy leaders should watch Medicare MFP as it changes Part D drug pricing and introduces new reconciliation challenges for ...

Tuesday afternoon, the House of Representatives voted in favor of a spending bill that includes major pharmacy benefit manager (PBM) reforms aimed at increasing price transparency for consumers and ...

DSHM Recruitment 2026: Big news has emerged for young people dreaming of a government job in the health department in Delhi. To strengthen the capital's healthcare system, the Delhi State Health ...

Recent significant rises in the use of ketamine by young people, and in the harms it can cause – in particular in relation to bladder damage, dependence, and drug-related deaths - have led to growing ...

PSSSB announced 331 Group D vacancies; exam includes 5 subjects. Exam has 100 MCQs for 100 marks to be completed in 2 hours. Part A is qualifying; Part B has GK, Reasoning, and more. Punjab Group D ...

Jan 15 (Reuters) - Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools and automated labs to unlock efficiency gains across ...

India’s pharmaceutical sector concluded a tumultuous 2025 — buffeted by global trade skirmishes, domestic safety crackdowns, and breakthroughs in innovation — yet poised for a strategic rebalance ...

The Karnataka Pharmacy College of Management Association (KPCMA) has urged the State government to revise the fees for the Diploma in Pharmacy (D. Pharm) programme. The association emphasizes that the ...

Company has now met all regulatory requirements for commencement of the phase II study in Australia All requirements for study initiation now complete with patient recruitment expected to start in Q1 ...

DDU Result 2025: Deen Dayal Upadhyaya Gorakhpur University (DDUGU) has announced the DDU Result 2025 for D.Pharm first and second-year students. The results are available on the university's official ...

On November 6, 2025, UroGen Pharma Ltd. (NASDAQ:URGN) reported its Q3 2025 results, highlighting strong growth in demand alongside its steady commercial expansion. Furthermore, preliminary October ...

COPENHAGEN, Denmark, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the third quarter ended September 30, 2025, and provided a business ...